Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Clinical trial NCT02527746 · COMPLETED
Trial details
- NCT number
- NCT02527746
- Sponsor
- EVIVE Biotechnology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.